Obesity Trial, Recruiting NCT07619989 Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07619989
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are living with obesity, or who are overweight and also have at least one weight-related health condition (such as high blood pressure or fatty liver disease), who have been taking a type of weight-loss medication called an incretin receptor agonist for at least 6 months, and who have lost 10% or less of their body weight during that time
  • People who are willing to sign a written consent form agreeing to take part

Who may not be able to join:

  • People who have certain medical conditions that can significantly affect body weight, such as Cushing's syndrome, thyroid disease that is not well controlled, or cancer (confirm with trial site)
  • People who have taken certain medications — other than incretin receptor agonists — in the past 3 months that can affect body weight, such as steroids (glucocorticoids) or antipsychotic medicines
  • People who have a skin infection or skin damage in or around the ear area
  • Women who are planning to become pregnant in the near future
  • People who are unable to have an MRI scan — for example, those who have metal implants in their body or who experience severe anxiety in enclosed spaces
  • People who have been diagnosed with diabetes
  • People who are unlikely to be able to complete the full 12-week programme due to practical reasons, such as frequent or extended travel

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yan Bi, MD, PhD, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

Phone: 6-25-83-105302

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Registry
ClinicalTrials.gov
Start date
21 April 2026
Est. completion
14 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percent Change in Body Weight From Baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov